60 Degrees Pharmaceuticals, Inc.
SXTP
$3.16
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -111.03% | -130.84% | 82.65% | 90.66% | 39.08% |
| Total Depreciation and Amortization | -36.49% | -27.57% | -11.27% | 11.00% | 27.45% |
| Total Amortization of Deferred Charges | -- | -100.00% | -98.22% | -74.57% | -36.74% |
| Total Other Non-Cash Items | 201.12% | 195.49% | -232.27% | -399.43% | -461.60% |
| Change in Net Operating Assets | -52.48% | 315.09% | -127.84% | -109.13% | -87.97% |
| Cash from Operations | -24.32% | 10.38% | -459.03% | -299.23% | -349.76% |
| Capital Expenditure | -80.21% | -8,766.67% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,962.44% | -1,590.95% | -11.07% | -3.51% | 3.00% |
| Cash from Investing | -1,529.94% | -1,710.57% | -198.85% | -95.53% | -92.85% |
| Total Debt Issued | -- | -100.00% | -100.00% | -53.03% | -30.25% |
| Total Debt Repaid | -- | 100.00% | -544.44% | -- | -- |
| Issuance of Common Stock | -5.69% | -5.69% | -- | 5,029.84% | 3,993.96% |
| Repurchase of Common Stock | 32.78% | 18.83% | 18.83% | 18.83% | 18.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 122.05% | 157.83% | 101.62% | 100.00% |
| Cash from Financing | 8.94% | 10.09% | 1,710.42% | 483.68% | 429.97% |
| Foreign Exchange rate Adjustments | -99.19% | 115.59% | 505.66% | 162.30% | 3,042.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.73% | -39.18% | 312.66% | 3,744.66% | 1,155.92% |